Wieland W. Wolf, Ph.D.
 
Short Profile
 
Wieland W. Wolf obtained a doctorate in biology from the University of Salzburg/Austria. As a member of the Board of the Germany-based Rentschler Holding GmbH & Co. KG, he is responsible for the strategy of the group’s biotech business. 
Prior to this position, he was the head of operations of Rentschler Biotechnologie GmbH from 1993 to 2005. During this term he led the company through its transformation from a product-oriented enterprise into an established service provider and CMO.
He had started his professional career in the development group of "Bioferon GmbH" as a molecular biologist contributing to the development, and later as director of production to the manufacturing of several biopharmaceutical drugs.
 
Furthermore, he is a Member of the Board of Trustees of the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB, Stuttgart, Germany), Vice Chairman of the Supervisory Board of Kenta Biotech AG (Bern, Switzerland), Deputy Chairman of the Biotechnology Department of the German Pharmaceutical Association (BPI), Member of the Dechema Study Group for Cell Culture Technology, and has been consultant to the German Ministry of Research and Technology.

 
Close window